Prolonging the withdrawal of life support in the ICU affects family satisfaction with care
Antares Pharma, Inc. today announced that its license partner, Ferring Pharmaceuticals has received additional regulatory approvals in Europe and Australia for use of Antares’ needle-free injection devices with its human growth hormone (hGH), Zomacton. Ferring has been notified recently that the mutual recognition process for European member states has been positively concluded for the Zomacton
Full Post: Needle-free injection device approved in Europe and Australia
Clinicians in the intensive care unit (ICU) often care for patients who are on several life support measures at once. When such a patient is dying and the decision is reached to withdraw life support, these clinicians may make an imperfect compromise in seeking to balance the complex needs of the patient and the patient’s family - they may remove the life support measures one at a time over a period of days, rather than withdrawing all at once.
According to a paper published in the Oct. 15, 2008, issue of the American Journal of Respiratory and Critical Care Medicine, this practice, referred to as sequential withdrawal, may be relatively common, and may have a varying impact on the family’s satisfaction with ICU care. This study was funded by the National Institute of Nursing Research (NINR), the lead Institute for end-of-life research at the National Institutes of Health (NIH).
“We found that sequential withdrawal of life support is not as rare a phenomenon as previously thought,” said J. Randall Curtis, M.D., MPH, the principal investigator of the study. “It occurred in nearly half of the patients we studied.”
“The decision to remove a loved one from life supporting treatment is typically very traumatic for families,” said NINR Director Patricia A. Grady, Ph.D., RN, FAAN. “Once a patient enters the ICU, clinicians may need to help family members develop realistic expectations based on the patient’s prognosis. This study highlights the importance of open communication between clinicians and the family.”
The data for this study came from a larger project involving ICUs in 15 hospitals across the Seattle and Tacoma area in Washington state. Dr. Curtis and colleagues examined the life support withdrawal process for 584 patients who died in the ICU or within 24 hours of discharge from the ICU, and surveyed the family members on their perceptions of the care provided.
The patients ranged in age from 19 to 99 years, with an average age of 72 years, 91 percent were white, and 61 percent were male. A medical chart review found that the patients received a median number of four life support therapies or interventions within their last five days of life: 99 percent had laboratory tests done, 83 percent were on mechanical ventilation, 76 percent received intravenous fluids, 52 percent were on vasopressor medications to sustain blood pressure, 33 percent received tube feedings, and 9 percent received renal dialysis.
When the decision was reached to remove life support, all measures were withdrawn on the same day for 54 percent of the patients. For the remaining 46 percent, the process of withdrawal took at least two days. Among these patients, dialysis was most often the first therapy withdrawn, and mechanical ventilation the last. Older patients, those with cancer, neurologic, or respiratory disease, and those experiencing pain tended to have a shorter duration of the withdrawal process, while trauma patients had the longest. The presence of a living will did not influence the duration of the withdrawal process.
Among the families, 95 percent participated in a family conference with the ICU clinicians during the last week of the patient’s life. Having more family members involved in making decisions tended to prolong the withdrawal process. When surveyed one to two months after the death, family members of patients who had a short ICU stay reported a lower satisfaction with the ICU care if the withdrawal process was extended over more than one day. However, for family members of patients who had a long ICU stay (eight days or more), satisfaction with care increased with a more extended duration of the withdrawal. In addition, family satisfaction with care was higher if the patient was off the ventilator at the time of death.
Of particular interest was the finding that the families of patients who had experienced a longer ICU stay tended to prefer the more extended, sequential withdrawal process. “This finding is in the opposite direction of our original hypothesis,” stated Dr. Curtis. “We believed that extending the withdrawal process would lower the satisfaction with care among all families. A longer duration of withdrawal of life support seems unlikely to benefit the patient, because it prolongs non-beneficial and sometimes painful therapies.”
“After making the decision to withdraw life support measures from a dying patient in the ICU, some physicians may slow down the withdrawal process to give the family more time to cope,” noted Dr. Grady. “The outcome of this study indicates that nurses and physicians need to continue to work with the family throughout the patient’s ICU stay to provide them with accurate information on which to base decisions, and prepare them emotionally for the possible loss of their loved one.”
A study of patients, at the Christie Hospital, Manchester, has shown that the decision to fund patient care depends more on where the patient lives, than the patient’s health circumstances, raising public concern regarding a “postcode lottery” since each decision is made solely by the patients’ local Primary Care Trust (PCT). The findings of this
Full Post: A post-code lottery still exists for cancer patients with “exceptional circumstances”
Total knee replacement (TKR) is a common treatment for osteoarthritis, a disease affecting more than 20 million Americans. However, the surgery poses risks and both patients and physicians must carefully assess its potential benefits and harm. Studies have shown that doctor-patient communication is correlated with outcomes and that patient satisfaction and commitment to treatment are
Full Post: Health-care providers and patients differ on views of knee replacement
A strategy to change practice in intensive care units was effective in implementing earlier nutritional support for critically ill patients, but the change did not result in a reduced risk of death or reduced length of stay in the ICU, according to a study in the December 17 issue of JAMA, the Journal of the
Full Post: Multi-faceted strategy improves nutritional support for ICU patients, but not outcomes
A major cross institutional research collaboration aimed at reducing the number of patients harmed in Australia has received $8.4 million in funding in the latest round of National Health and Medical Research Council (NHMRC) program grants. With current research showing that patient harm occurs in 10 per centof hospital admissions, and that less than
Full Post: $8.4 million research grant to improve patient safety in Australia
Ventricular assist devices, or VADs - surgically-placed mechanical pumps that can support failing hearts or buy time to transplant - are associated with high hospital costs and high rates of early death among Medicare recipients, say researchers at Duke University Medical Center. Their study, appearing in the November 26 issue of the Journal of the
Full Post: Study looks at ventricular assist device outcomes